Article
In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus.
Chemotherapy - 1 Jan 2000
Esposito S, Noviello S, Ianniello F, Novelli A
Abstract excerpt
The aim of the present study was to evaluate the in vitro activity of moxifloxacin (BAY 12-8039) compared to ciprofloxacin, ofloxacin and sparfloxacin against 156 group A beta-hemolytic Streptococcus strains. Sixty strains were macrolide-, lincosamide- and streptogramin-B-susceptible; 16 strains exhibited a constitutive resistance phenotype; 32 strains exhibited an inducible phenotype, and 48 strains were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
